Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Taiwan Advanced Nanotech Inc. (6797:TWSE), powered by AI.
Taiwan Advanced Nanotech Inc. is currently trading at $13.70. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Taiwan Advanced Nanotech Inc. on Alpha Lenz.
View Taiwan Advanced Nanotech Inc.'s valuation metrics on Alpha Lenz.
“Taiwan Advanced Nanotech Inc.'s ROE is -25.5%. Explore profitability and growth together.”
Ask for details →Taiwan Advanced Nanotech Inc. is a healthcare equipment manufacturer specializing in advanced molecular diagnostics technologies. The company focuses on the design and production of automated nucleic acid extraction instruments, nanomagnetic beads, and purification reagents, offering total solutions for DNA and RNA extraction from diverse biological samples such as blood, tissue, plants, and microorganisms. Its product portfolio includes automated extraction machines, specialized reagent kits, and consumables like spin tips and deep well plates, all of which are supported by international certifications such as GMP, ISO 13485, FDA, and CE approvals. Established in 2004 and headquartered in Taoyuan, Taiwan, Taiwan Advanced Nanotech Inc. serves both domestic and global markets and holds patents across Europe, North America, and several Asian countries. The company's technologies are essential to diagnostic laboratories, hospitals, and research institutions, underpinning a wide range of applications from medical diagnostics to disease monitoring. By providing OEM/ODM services, Taiwan Advanced Nanotech Inc. further supports innovation and customization within the biotechnology sector. Its leadership in nucleic acid extraction and automated diagnostics positions the company as a key enabler for advancing molecular medicine and public health.
“Taiwan Advanced Nanotech Inc.'s ROE is -25.5%. Explore profitability and growth together.”
Ask for details →Taiwan Advanced Nanotech Inc. (ticker: 6797) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 13.7 with a P/E ratio of -x and P/B of -x.
ROE is -25.46% and operating margin is -150.51%. Annual revenue is $154M.